Advanced Accelerator Applications

This study is testing the safety and measuring the radiation dose of a drug called Lutathera in teenagers (ages 12 to 18) with specific rare tumors. Lutathera is a targeted radiation therapy that seeks out and delivers radiation to tumor cells. The main goals are to see how much …

This study tested whether a targeted radiation drug called Lutathera, combined with a hormone therapy, works better than high-dose hormone therapy alone to control the growth of advanced neuroendocrine tumors in the digestive system. It involved 226 patients with more aggressive …

This study is collecting long-term safety information on Lutathera, a treatment already approved for advanced neuroendocrine tumors. Researchers are following 1,014 patients who have already received this treatment to monitor for rare or delayed side effects, particularly looking…